Tissue Engineering, Parts A, B, & C

Tissue Engineering is the preeminent, biomedical journal advancing the field with cutting-edge research and applications that repair or regenerate portions or whole tissues. This multidisciplinary journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine. Tissue Engineering is divided into three parts, providing a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues.

Tissue Engineering, Part A: Research Advances

Tissue Engineering, Part A: Research Advances serves as the authoritative peer-reviewed biomedical journal advancing the field with cutting-edge hypothesis-driven research focused on tissue repair or regeneration. This multidisciplinary journal brings together the fundamental and applied principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine.

Tissue Engineering, Part A: Research Advances launched in 1994 and marks the first academic journal devoted to covering the field of tissue engineering. The journal has served as a central forum for groundbreaking scientific research and developments of clinical applications from leading experts in the field that will enable the functional replacement of tissues. The journal focuses specifically on the theoretical, computational, and experimental aspects for the development of therapeutic strategies to repair or regenerate tissue and organ function.

The journal provides “instant online” publication of accepted articles within 72 hours of acceptance and publishes 12 double issues online and in print annually. The journal is Green Open Access compliant and supports various options for authors to publish their work under a CC-BY Open Access license.

Complete coverage includes:

• Basic and clinical advances in tissue engineering and regenerative medicine
• Novel approaches to regenerative medicine applying controlled/sustained release strategies
• Surface modification technologies; protein adsorption and cell behavior
• In vivo responses to cell-material constructs
• Bioactive molecules and the development of carrier systems
• Bioreactors for 2D and 3D tissue growth
• Applied nanotechnology and/or non-invasive imaging approaches
• Inductive scaffolds and matrices
• Organs-on-a-chip and smart systems
• Self-assembly materials
• Artificial Intelligence in tissue engineering and regenerative medicine
• Cell therapy
• Immunotherapy
• Commercial development of tissue engineering and regenerative medicine products

Tissue Engineering Part A: Research Advances is under the editorial oversight and leadership of Co-Editors-in-Chief Antonios G. Mikos, PhD, Rice University, and John P. Fisher, PhD, Fischell Department of Bioengineering, University of Maryland. For pre-submission inquiries, please contact Managing Editor Olivia Mulder at teeditor@rice.edu. 

Audience: Biomedical and biomaterials engineers, biomaterials scientists, cell and molecular biologists, chemists, stem cell researchers, biochemists, biophysicists, wound care specialists, surgeons specializing in chronic and degenerative diseases, medical researchers, clinicians, and surgeons.

Tissue Engineering, Part B: Reviews

Tissue Engineering, Part B: Reviews serves as the authoritative peer-reviewed biomedical journal advancing the field with cutting-edge review articles focused on the repair or regeneration of tissues and organs. This review journal brings together the principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine.

The journal continues to serve as an influential and central forum for groundbreaking scientific research and developments from leading experts in the field. Tissue Engineering, Part B: Reviews meets the urgent need for high-quality review articles by presenting critical literature overviews and systematic summaries of research within the field to assess the current standing and future directions within relevant areas and technologies.

The journal provides “instant online” publication of accepted articles within 72 hours of acceptance and publishes bi-monthly online and print issues. The journal is Green Open Access compliant and supports options for authors to publish their work under a CC-BY Open Access license.

Complete coverage includes Review Articles on the following topics:

• Future directions in regenerative medicine within relevant areas and technologies
• Surface modification technologies; protein adsorption and cell culture
• In vivo responses to cell-material constructs
• Development of drug and cell carriers and their advanced delivery systems
• Bioreactors for 2D and 3D tissue growth
• Applied nanotechnology and/or non-invasive imaging approaches
• inductive scaffolds and matrices
• Organoid, organs-on-a-chip and microfluidic systems
• Self-assembly materials
• Artificial Intelligence in tissue engineering and regenerative medicine
• Cell therapy
• Immunotherapy
• Review of commercial development of tissue engineering and regenerative medicine products

Tissue Engineering, Part B: Reviews is under the editorial oversight and leadership of Co-Editors-in-Chief Katja Schenke-Layland, MSc, PhD, Institute of Biomedical Engineering at Eberhard Karls University Tübingen, and Heungsoo Shin, PhD, Hanyang University. For pre-submission inquiries, please contact Managing Editor Olivia Mulder at teeditor@rice.edu. 

Audience: Biomedical and biomaterials engineers, biomaterials scientists, cell and molecular biologists, chemists, stem cell researchers, biochemists, biophysicists, wound care specialists, surgeons specializing in chronic and degenerative diseases, medical researchers, clinicians, and surgeons.

Tissue Engineering, Part C: Methods

Tissue Engineering, Part C: Methods serves as the authoritative peer-reviewed biomedical journal advancing the field with cutting-edge Methods and Protocols articles focused on tissue repair or regeneration. This methods journal brings together the fundamental and applied principles of engineering and life sciences in the creation of artificial tissues and regenerative medicine.

The journal continues to serve as an influential and central forum for valuable methods research and developments from leading experts in the field. Tissue Engineering, Part C: Methods meets the demand for high-quality methods and protocols covering innovative tools and assays in scaffold development, stem cells and biologically active molecules to advance the field and to support clinical translation.

The journal provides “instant online” publication of accepted articles within 72 hours of acceptance and publishes monthly online and print issues. The journal is Green Open Access compliant and supports options for authors to publish their work under a CC-BY Open Access license.

Coverage includes Methods and Protocols on the following topics:

• Methods and protocols in regenerative medicine within relevant areas and technologies
• Tools and assays in scaffold development, stem cells, and active molecules
• Surface modification technologies; protein adsorption and cell behavior
• in vivo response to cell-material constructs
• Bioagents and the development of carrier systems
• Bioreactors for 2D and 3D tissue growth
• Applied nanotechnology and/or non-invasive approaches
• Inductive scaffolds and matrices
• Organs-on-a-chip and smart systems
• Self-assembly materials
• Artificial Intelligence in tissue engineering and regenerative medicine
• Cell therapy
• Immunotherapy
• Applications of commercial tools in tissue engineering and regenerative medicine

Tissue Engineering, Part C: Methods is under the editorial oversight and leadership of Co-Editors-in-Chief John A. Jansen, DDS, PhD, Department of Regenerative Biomaterials, Radboud University Nijmegen Medical Center, and Xiumei Wang, PhD, Institute for Regenerative Medicine and Biomimetic Materials, School of Materials Science and Engineering, Tsinghua University. For pre-submission inquiries, please contact Managing Editor Olivia Mulder at teeditor@rice.edu. 

Audience: Biomedical and biomaterials engineers, biomaterials scientists, cell and molecular biologists, chemists, stem cell researchers, biochemists, biophysicists, wound care specialists, surgeons specializing in chronic and degenerative diseases, medical researchers, clinicians, and surgeons.

Various members of the editorial board are interviewed regularly and featured in the news for their breakthroughs in tissue and organ developments.

Audience: Biomedical and biomaterials engineers, materials and biomaterials scientists, stem cell researchers, biochemists, biophysicists, wound care specialists, surgeons, and government regulators, among others.

Tissue Engineering provides “Instant Online” publication 72 hours after acceptance.